These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19761982)

  • 1. Ultrasound contrast agent safety: from anecdote to evidence.
    Main ML
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1057-9. PubMed ID: 19761982
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients.
    Abdelmoneim SS; Bernier M; Scott CG; Dhoble A; Ness SA; Hagen ME; Moir S; McCully RB; Pellikka PA; Mulvagh SL
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1048-56. PubMed ID: 19761981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure: a cohort study.
    Abdelmoneim SS; Bernier M; Scott CG; Dhoble A; Ness SA; Hagen ME; Moir S; McCully RB; Pellikka PA; Mulvagh SL
    Circ Cardiovasc Imaging; 2010 May; 3(3):240-8. PubMed ID: 20233859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmias in rat hearts exposed to pulsed ultrasound after intravenous injection of a contrast agent.
    Zachary JF; Hartleben SA; Frizzell LA; O'Brien WD
    J Ultrasound Med; 2002 Dec; 21(12):1347-56; discussion 1343-45. PubMed ID: 12494976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound contrast agents: balancing safety versus efficacy.
    Main ML; Goldman JH; Grayburn PA
    Expert Opin Drug Saf; 2009 Jan; 8(1):49-56. PubMed ID: 19236217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety With Echocardiographic Contrast Agents.
    Muskula PR; Main ML
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28377467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does contrast echocardiography induce increases in markers of myocardial necrosis, inflammation and oxidative stress suggesting myocardial injury?
    Knebel F; Schimke I; Eddicks S; Walde T; Ziebig R; Schattke S; Baumann G; Borges AC
    Cardiovasc Ultrasound; 2005 Aug; 3():21. PubMed ID: 16107209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of contrast dobutamine stress echocardiography: a single center experience.
    Timperley J; Mitchell AR; Thibault H; Mirza IH; Becher H
    J Am Soc Echocardiogr; 2005 Feb; 18(2):163-7. PubMed ID: 15682054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography.
    Herzog CA
    JAMA; 2008 May; 299(17):2023-5. PubMed ID: 18460662
    [No Abstract]   [Full Text] [Related]  

  • 10. Does contrast echocardiography with Optison induce myocardial necrosis in humans?
    Borges AC; Walde T; Reibis RK; Grohmann A; Ziebig R; Rutsch W; Schimke I; Baumann G
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 1):1080-6. PubMed ID: 12373250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts.
    Kalra A; Shroff GR; Erlien D; Gilbertson DT; Herzog CA
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):206-7. PubMed ID: 24524748
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety profile of ultrasound enhancing agents in echocardiography.
    Kumar S; Purtell C; Peterson A; Gibbons P; Khan AM; Heitner SB
    Echocardiography; 2019 Jun; 36(6):1041-1044. PubMed ID: 31038768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of contrast-enhanced echocardiography within 24 h after acute myocardial infarction.
    Nucifora G; Marsan NA; Siebelink HM; van Werkhoven JM; Schuijf JD; Schalij MJ; Poldermans D; Holman ER; Bax JJ
    Eur J Echocardiogr; 2008 Nov; 9(6):816-8. PubMed ID: 18635517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of left ventricular systolic function using contrast two-dimensional echocardiography with a high-frequency transducer in the awake murine model of myocardial infarction.
    Suehiro K; Takuma S; Shimizu J; Hozumi T; Yano H; Cardinale C; DiTullio MR; Wang J; Smith CR; Burkhoff D; Homma S
    Jpn Circ J; 2001 Nov; 65(11):979-83. PubMed ID: 11716251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primum non nocere? Why can't we use second generation ultrasound contrast agents for the examination of children?
    Piskunowicz M; Kosiak W; Irga N
    Ultraschall Med; 2011 Feb; 32(1):83-6. PubMed ID: 21305439
    [No Abstract]   [Full Text] [Related]  

  • 16. Echocardiography contrast for image optimization: beyond confidence, it is a matter of accuracy.
    Pellikka PA; Mulvagh SL
    JACC Cardiovasc Imaging; 2008 Mar; 1(2):153-5. PubMed ID: 19356421
    [No Abstract]   [Full Text] [Related]  

  • 17. A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent.
    Exuzides A; Main ML; Colby C; Grayburn PA; Feinstein SB; Goldman JH
    JACC Cardiovasc Imaging; 2010 Jun; 3(6):578-85. PubMed ID: 20541713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylactoid response to Optison(R) and its effects on pulmonary function in two dogs.
    Yamaya Y; Niizeki K; Kim J; Entin P; Wagner H; Wagner PD
    J Vet Med Sci; 2004 Nov; 66(11):1429-32. PubMed ID: 15585961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts.
    Parker JM; Weller MW; Feinstein LM; Adams RJ; Main ML; Grayburn PA; Cosgrove DO; Goldberg BA; Darge K; Nihoyannopoulos P; Wilson S; Monaghan M; Piscaglia F; Fowlkes B; Mathias W; Moriyasu F; Chammas MC; Greenbaum L; Feinstein SB
    Am J Cardiol; 2013 Oct; 112(7):1039-45. PubMed ID: 23816393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bubble trouble: anaphylactic shock, threatened myocardial infarction, and transient renal failure after intravenous echo contrast for left ventricular cavity opacification preceding dobutamine stress echo.
    Ionescu A
    Eur J Echocardiogr; 2009 Jul; 10(5):707-10. PubMed ID: 19525512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.